The Intersection Between Genetic Engineering and Immunotherapy: Taking a BiTE out of Glioblastoma

摘要

Conventional methods for the treatment of glioblastoma multiforme (GBM) are nonspecific and are limited by the consequent damage to normal brain tissue. Such me.